Heterogeneity in cardiac amyloidosis care across Europe: a key opinion leader survey
Variations in ATTR-CM care across Europe highlight key areas for improvement and reveal where interventions could have the greatest impact, as differences in the number of specialized centers, variability in time to treatment initiation, and unequal access to therapies contribute to these disparities.